5Griffin MR. Epidemiology of nonsteroidal antl-inflammatory drug associated gastrointestinal injury[J]. Am J Med, 1998,104(1) :23 - 29.
二级参考文献20
1[1]Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;1:462-464.
2[3]Cryer B, Redfern JS, Goldschmiedt M, et al. Effect of aging on gastric and cluodenal mucosal prosta glandin coneentrations in humans.Gastroentcrology 1992;102(4 pt 1):1118-1123.
3[5]Aalykle C, Lauritsen JM, Hallas J, et al. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs:a case-control study. Gastroenterology 1999;116:1305-1309.
4Kim JG, Graham DY. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAIDs therapy. The misoprostol study group. Am J Gastroenterol,1994, 89:203-207.
5Wu CY, Poon SK, Chen GH, et al. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol, 1999,34:234-237.
6Weil J, Colin-Jones D, Langnan M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ, 1995,310:827-830.
7Soll A . Pathogenesis of non-steroidal anti-inflammatory drugs-related upper gastrointestinal toxicity. Am J Med, 1998,105 (SA) :10S-16S.
8Cryer B, Redfem JS, Goldschmiedt M, et al. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology, 1992,102(4 Pt 1) :1118-1123.
9Aalykke C, Lauritsen JM, Hallas J, et al. Helicobacter pylori and risk of ulcer bleeding among user of non-steroidal anti-inflammatory drugs: a case-control study. Gastroenterology, 1999, 116: 1305-1309.
10Frederick MG, Ott DJ, Grishaw EK, et al. Functional abnormalities of the pharynx: a prospective analysis of radiographic abnormalities relative to age and symptoms. Am J Roentgenol, 1996, 166:353 ～357.
